107. 若年性特発性関節炎 Juvenile idiopathic arthritis Clinical trials / Disease details

臨床試験数 : 441 / 薬物数 : 282 - (DrugBank : 56) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 142

4 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00144625 (ClinicalTrials.gov)	February 2005	2/9/2005	Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)	An Open-label, Extension, Phase III Study to Evaluate the Long-term Safety, Efficacy and PK of MRA in Patients With pJIA Who Participated in Study MRA318JP	Polyarticular Juvenile Idiopathic Arthritis	Drug: MRA(Tocilizumab)	Chugai Pharmaceutical	NULL	Completed	2 Years	19 Years	Both	19	Phase 3	NULL
2	NCT00144664 (ClinicalTrials.gov)	November 2004	2/9/2005	Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)	An Open-Label, Phase III Study to Evaluate the Efficacy, Safety and PK of MRA in Patients With pJIA	Systemic Juvenile Idiopathic Arthritis	Drug: MRA(Tocilizumab)	Chugai Pharmaceutical	NULL	Completed	2 Years	19 Years	Both	19	Phase 3	NULL
3	NCT00144612 (ClinicalTrials.gov)	July 2004	2/9/2005	Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)	An Open-label, Extension, Phase III Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With sJIA Who Participated in Studies MRA011JP or MRA316JP	Systemic Juvenile Idiopathic Arthritis	Drug: MRA(Tocilizumab)	Chugai Pharmaceutical	NULL	Completed	2 Years	19 Years	Both	60	Phase 3	NULL
4	NCT00144599 (ClinicalTrials.gov)	May 2004	2/9/2005	Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)	A Double-Blind, Phase III Study to Evaluate the Efficacy, Safety and PK of MRA in Patients With sJIA	Systemic Juvenile Idiopathic Arthritis	Drug: MRA(Tocilizumab);Drug: placebo	Chugai Pharmaceutical	NULL	Completed	2 Years	19 Years	Both	56	Phase 3	NULL